OCEA Ocean Biomedical: יחס מחיר להכנסות חזויות

Ocean Biomedical, Inc. (OCEA) maintains business resilience through FDA patents and Brown University licenses. The forward price-to-sales ratio on GURU.Markets reflects the valuation trend, where represents the latest metric reading. The company relies on a closed-loop antibody system to combat cancer and malaria, attracting top researchers through a commercialization system for their scientific discoveries.
פילוחי מדדים ואנליטיקה של חברת Ocean Biomedical Corp (OCEA)

When constructing a long-term portfolio, it is critical to correlate market capitalization with expected revenue to determine an asset's degree of overvaluation. The forward P/S ratio measures a company's value relative to projected sales, which allows for an assessment of Ocean Biomedical, Inc. (OCEA) expansion potential in oncology through the scaling of B2B partnerships by tracking price momentum on this chart.